This investigation aimed to elucidate if rs1859168 and rs7158663 genetic variants are linked with increased NPC susceptibility or development and assess whether these polymorphisms could affect HOTTIP and MEG3 expressions and their possible correlations with the clinicopathological features. This evidence concerns the gene MEG3 and nasopharyngeal carcinoma.